Planning Grant for TOPS for Breast Cancer Survivors
The purpose of this study is to help make a community led weight loss program known as Take Off Pounds Sensibly (TOPS) more relevant for breast cancer survivors. This study is made up to two parts. The first part includes using focus groups to review current materials that the investigators plan to use in upcoming TOPS classes and provide feedback. Focus groups will be made up of women who are breast cancer survivors. The second part includes taking the feedback received from these focus groups and use this…
Conditions studied
Breast Cancer, Weight Loss
About this study
The purpose of this study is to help make a community led weight loss program known as Take Off Pounds Sensibly (TOPS) more relevant for breast cancer survivors. This study is made up to two parts. The first part includes using focus groups to review current materials that the investigators plan to use in upcoming TOPS classes and provide feedback. Focus groups will be made up of women who are breast cancer survivors. The second part includes taking the feedback received from these focus groups and use this feedback to tailor TOPS classes for breast cancer survivors. This ClinicalTrials.gov record is specific to the second part of the study.
Interventions
- Other: TOPS Classes — Attend Dietician-Led Sessions
Primary outcomes
- Number of invitations sent through the electronic health record to get 25 individuals consented to the study (1-2 months)
- Percentage of TOPS group session attendance (12 months)
- Number of participants who stay in the study (3 months, 6 months, 9 months, 12 months)
- Number of participants who transition from the initiation phase to the maintenance phase (12 months)
- Number of participants who continue to transmit weight and BP data once they transition to the maintenance phase (9 months, 12 months)
- Percent of Weight Loss (Up to 12 Months)
Eligibility information
Study locations
- Duke University, Durham, North Carolina 27710 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.